Entering text into the input field will update the search result below

Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Jul. 22, 2014 2:53 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Organ Preservation Solutions Market valued at USD 0.06 billion and is expected to grow at a CAGR of 16.5% during the forecast period 2013 to 2019 to reach a market value of USD 0.20 billion by 2019.Organ Preservation Solutions Market valued at USD 0.06 billion and is expected to grow at a CAGR of 16.5% during the forecast period 2013 to 2019 to reach a market value of USD 0.20 billion by 2019.

Browse Organ Preservation Solutions Market Report with Full TOC at http://www.transparencymarketresearch.com/organ-preservation-solutions.html

Organ preservation solutions help in preserving organs for long when they are not inside the living body,which makes them vulnerable to environment outside the human body.Organs that are removed from the human body are preserved using these solutions for various purposes such as organ transplant proceduresandresearch and development of drugs and biologics. The global market for organ preservation solutionshas been estimated togrowat the rate of 16.5% during the forecast period 2013 to 2019. This growth will be primarily driven by the increasing number of patients who are awaiting organ transplants, since these preservation solutions will enable survival of the organs outside the human body post donation by living or deceased donors. In addition, the rising incidences of organ failure in the patient population owing to changes in lifestyles such as smoking, alcohol and fast foodconsumption, along with rise in geriatric population, especially in developed nations such as U.S. and U.K., will also propel the growth of this market. Likewise, increase in per capita healthcare expenditure and theimprovingreimbursement scenarios for organ transplant procedures in various nations such as U.S., U.K. and India will also support the growth of this market.

This report studiesthe market foreight major solutions for preserving organs, amongst which Viaspan and Custodiol together account for the majority share (over75%) of total market in terms of revenue. During the forecast period 2013 to 2019, the Custodiol market is expected to grow at the highest CAGR of 17.1%. This growth is attributed to its extensive utilization for preserving various organs such as kidney and liver, since it is capable of preserving multiple organs unlike other solutions including Perfadex and HBS solution.

The different techniques utilized to preserve organs are static cold storage (SCS),hypothermic perfusion preservation (HPP) and others. HPP is a machine perfusion technique and maintains continuous supply of the solution needed by organs, unlike SCS that does not allow continuous contact of the organ with the solution.This property increases the survival duration of organs which will in turn augment its demand in the market. The HPP market is expected to grow at a CAGR of 19.2% during the forecast period 2013 to 2019.

The European region accounted for the largest share in terms of revenue of the total global organ preservation solutions market in 2012, and is expected to grow at the highest CAGR of 17.3% during the forecast period 2013 to 2019. This is due to the presence of a large number of organ donors in the region. For instance, in 2011 total number of deceased organ donors in the U.K. was around 1,056 according to the European Commission (EC). Also, the European region exhibited highest rate of aging of population which will also help propel the growth of this market.

The global organ preservation solutions market is ruled by players such as Teva Pharmaceutical Industries Ltd.,Bristol-Myers Squibb, Dr. Franz KöhlerChemie GmbH, XVIVO Perfusion AB andBioLife Solutions, Inc. These companies together accounted for around 90% of the total market revenue in 2012. Some other important players operating in the market include CryoLife, Inc., Lifeline Scientific, Claris Lifesciences Ltd., 21st Century Medicine and BioTime, Inc.

The global organ preservation solutions market has been segmented as below:

Organ Preservation SolutionsMarket, by Solution

Viaspan

Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)

Renograf

Hypothermosol

Perfadex

Lifor

Human bioSystem (HBS) Solution

siRNA Transplant Solutions

Others

Organ Preservation SolutionsMarket, by Technique

Hypothermic Perfusion Preservation (HPP)

Static Cold Storage (SCS)

Others

Organ Preservation SolutionsMarket, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)For Sample Report Visit On:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1786

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You